Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 9.88962112 |
2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.78646241 |
3 | epoxygenase P450 pathway (GO:0019373) | 8.65302797 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54366956 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.54366956 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.20438879 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20438879 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.75644691 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.34220690 |
10 | drug metabolic process (GO:0017144) | 6.13192477 |
11 | tryptophan catabolic process (GO:0006569) | 6.09863021 |
12 | indole-containing compound catabolic process (GO:0042436) | 6.09863021 |
13 | indolalkylamine catabolic process (GO:0046218) | 6.09863021 |
14 | kynurenine metabolic process (GO:0070189) | 5.98452891 |
15 | oxidative demethylation (GO:0070989) | 5.96264067 |
16 | bile acid biosynthetic process (GO:0006699) | 5.88209841 |
17 | negative regulation of fibrinolysis (GO:0051918) | 5.81006714 |
18 | tryptophan metabolic process (GO:0006568) | 5.73594616 |
19 | glyoxylate metabolic process (GO:0046487) | 5.72588545 |
20 | urea metabolic process (GO:0019627) | 5.70932431 |
21 | urea cycle (GO:0000050) | 5.70932431 |
22 | regulation of protein activation cascade (GO:2000257) | 5.63210936 |
23 | regulation of fibrinolysis (GO:0051917) | 5.58926148 |
24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.58255304 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58213052 |
26 | complement activation, alternative pathway (GO:0006957) | 5.57965930 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.51472688 |
28 | protein carboxylation (GO:0018214) | 5.51472688 |
29 | regulation of plasminogen activation (GO:0010755) | 5.40651222 |
30 | cysteine metabolic process (GO:0006534) | 5.31812413 |
31 | sulfur amino acid catabolic process (GO:0000098) | 5.24600390 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.24275744 |
33 | regulation of complement activation (GO:0030449) | 5.21377566 |
34 | regulation of humoral immune response (GO:0002920) | 5.09140825 |
35 | serine family amino acid catabolic process (GO:0009071) | 5.08228963 |
36 | bile acid metabolic process (GO:0008206) | 5.04754122 |
37 | ethanol metabolic process (GO:0006067) | 4.94133887 |
38 | reverse cholesterol transport (GO:0043691) | 4.91647390 |
39 | phenylpropanoid metabolic process (GO:0009698) | 4.91600816 |
40 | aromatic amino acid family metabolic process (GO:0009072) | 4.90069070 |
41 | regulation of cholesterol esterification (GO:0010872) | 4.88281104 |
42 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.85888099 |
43 | negative regulation of hemostasis (GO:1900047) | 4.85638618 |
44 | negative regulation of blood coagulation (GO:0030195) | 4.85638618 |
45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83100915 |
46 | regulation of triglyceride catabolic process (GO:0010896) | 4.82059944 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81948449 |
48 | protein-lipid complex remodeling (GO:0034368) | 4.81948449 |
49 | macromolecular complex remodeling (GO:0034367) | 4.81948449 |
50 | tyrosine metabolic process (GO:0006570) | 4.77543933 |
51 | homocysteine metabolic process (GO:0050667) | 4.76987494 |
52 | S-adenosylmethionine metabolic process (GO:0046500) | 4.64524445 |
53 | triglyceride homeostasis (GO:0070328) | 4.63669835 |
54 | acylglycerol homeostasis (GO:0055090) | 4.63669835 |
55 | alpha-amino acid catabolic process (GO:1901606) | 4.59747578 |
56 | phospholipid efflux (GO:0033700) | 4.59600066 |
57 | amino-acid betaine metabolic process (GO:0006577) | 4.54219814 |
58 | lysine catabolic process (GO:0006554) | 4.52624884 |
59 | lysine metabolic process (GO:0006553) | 4.52624884 |
60 | negative regulation of sterol transport (GO:0032372) | 4.51490508 |
61 | negative regulation of cholesterol transport (GO:0032375) | 4.51490508 |
62 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.47248111 |
63 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.47248111 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 4.41860189 |
65 | negative regulation of coagulation (GO:0050819) | 4.40581192 |
66 | bile acid and bile salt transport (GO:0015721) | 4.38521522 |
67 | negative regulation of wound healing (GO:0061045) | 4.38334894 |
68 | cellular ketone body metabolic process (GO:0046950) | 4.37506083 |
69 | glycine metabolic process (GO:0006544) | 4.36438864 |
70 | coenzyme catabolic process (GO:0009109) | 4.34810092 |
71 | imidazole-containing compound metabolic process (GO:0052803) | 4.32876349 |
72 | indolalkylamine metabolic process (GO:0006586) | 4.31069741 |
73 | cholesterol efflux (GO:0033344) | 4.28795693 |
74 | glutamate metabolic process (GO:0006536) | 4.22592519 |
75 | cellular amino acid catabolic process (GO:0009063) | 4.21563410 |
76 | positive regulation of hemostasis (GO:1900048) | 4.21555009 |
77 | positive regulation of blood coagulation (GO:0030194) | 4.21555009 |
78 | amine catabolic process (GO:0009310) | 4.21438563 |
79 | cellular biogenic amine catabolic process (GO:0042402) | 4.21438563 |
80 | alkaloid metabolic process (GO:0009820) | 4.19438242 |
81 | cellular glucuronidation (GO:0052695) | 4.16248706 |
82 | fibrinolysis (GO:0042730) | 4.13695702 |
83 | serine family amino acid metabolic process (GO:0009069) | 4.12872527 |
84 | benzene-containing compound metabolic process (GO:0042537) | 4.08696625 |
85 | plasma lipoprotein particle assembly (GO:0034377) | 4.04310672 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03863304 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 4.03162727 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01580405 |
89 | ethanol oxidation (GO:0006069) | 3.99631209 |
90 | arginine metabolic process (GO:0006525) | 3.99554680 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 3.96606585 |
92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.96133342 |
93 | flavonoid metabolic process (GO:0009812) | 3.91834870 |
94 | aldehyde catabolic process (GO:0046185) | 3.91626993 |
95 | complement activation, classical pathway (GO:0006958) | 3.90864515 |
96 | positive regulation of coagulation (GO:0050820) | 3.87925328 |
97 | protein activation cascade (GO:0072376) | 3.86929279 |
98 | complement activation (GO:0006956) | 3.86437790 |
99 | drug catabolic process (GO:0042737) | 3.84645556 |
100 | hormone catabolic process (GO:0042447) | 3.82664705 |
101 | negative regulation of protein activation cascade (GO:2000258) | 3.81938248 |
102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81775038 |
103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81775038 |
104 | phospholipid homeostasis (GO:0055091) | 3.79526991 |
105 | cofactor catabolic process (GO:0051187) | 3.78541353 |
106 | ketone body metabolic process (GO:1902224) | 3.78485092 |
107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77772491 |
108 | cholesterol homeostasis (GO:0042632) | 3.75322335 |
109 | positive regulation of lipid catabolic process (GO:0050996) | 3.74503562 |
110 | negative regulation of lipase activity (GO:0060192) | 3.73196147 |
111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72980609 |
112 | intestinal cholesterol absorption (GO:0030299) | 3.72531814 |
113 | response to mercury ion (GO:0046689) | 3.71578970 |
114 | regulation of cholesterol homeostasis (GO:2000188) | 3.71375220 |
115 | opsonization (GO:0008228) | 3.71074424 |
116 | cytolysis (GO:0019835) | 3.70453165 |
117 | sterol homeostasis (GO:0055092) | 3.69136334 |
118 | glucuronate metabolic process (GO:0019585) | 3.68518452 |
119 | uronic acid metabolic process (GO:0006063) | 3.68518452 |
120 | negative regulation of complement activation (GO:0045916) | 3.68060039 |
121 | organic acid catabolic process (GO:0016054) | 3.68000140 |
122 | carboxylic acid catabolic process (GO:0046395) | 3.68000140 |
123 | plasma lipoprotein particle organization (GO:0071827) | 3.66906383 |
124 | * acute-phase response (GO:0006953) | 3.65593548 |
125 | regulation of apoptotic cell clearance (GO:2000425) | 3.63150089 |
126 | protein-lipid complex assembly (GO:0065005) | 3.62296733 |
127 | acetyl-CoA metabolic process (GO:0006084) | 3.60534542 |
128 | regulation of acute inflammatory response (GO:0002673) | 3.55608498 |
129 | heme transport (GO:0015886) | 3.55565720 |
130 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.54882760 |
131 | * acute inflammatory response (GO:0002526) | 3.52859317 |
132 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.45089390 |
133 | xenobiotic metabolic process (GO:0006805) | 3.40169465 |
134 | regulation of lipoprotein particle clearance (GO:0010984) | 3.38052769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33435588 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13967549 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.97799775 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49985591 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30292781 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.20202797 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84160970 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.11402219 |
9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96691903 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05669578 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0174458 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95483118 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93811571 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64332393 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57932816 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53049405 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50034158 |
18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40893129 |
19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30699951 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25126755 |
21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20838628 |
22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20244866 |
23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18831231 |
24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13572220 |
25 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09995977 |
26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03892062 |
27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99436647 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93426196 |
29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93201212 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90595026 |
31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90425105 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85342348 |
33 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85142231 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83803581 |
35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82649355 |
36 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.82604842 |
37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81711035 |
38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80753621 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80292573 |
40 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.77522778 |
41 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76523451 |
42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76015362 |
43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74566072 |
44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73832441 |
45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72503577 |
46 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72343913 |
47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72230791 |
48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71877420 |
49 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71595284 |
50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70929717 |
51 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70911054 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70568895 |
53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69936227 |
54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69858199 |
55 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.69533710 |
56 | NFYA_21822215_ChIP-Seq_K562_Human | 0.69176818 |
57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68204961 |
58 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66023086 |
59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65251871 |
60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65251871 |
61 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.62860204 |
62 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62026675 |
63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61715238 |
64 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.61710032 |
65 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61602242 |
66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60843004 |
67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60830746 |
68 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60085866 |
69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.59812630 |
70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.59611064 |
71 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59460857 |
72 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.58940063 |
73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58696726 |
74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.58499176 |
75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57900096 |
76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57353204 |
77 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56854863 |
78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56379437 |
79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.56182090 |
80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55767527 |
81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.55287837 |
82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53825009 |
83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53217023 |
84 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.53142984 |
85 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.53079660 |
86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52888387 |
87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.52842723 |
88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52693887 |
89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.51279264 |
90 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.51187195 |
91 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50761803 |
92 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.50734455 |
93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50626569 |
94 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.50464521 |
95 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50450975 |
96 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50032203 |
97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.49810994 |
98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49178682 |
99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.48685808 |
100 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.48202390 |
101 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47651083 |
102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47153666 |
103 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47050626 |
104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.46825408 |
105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45656977 |
106 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45564253 |
107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45555282 |
108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44838360 |
109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44825126 |
110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44626068 |
111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44121387 |
112 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42631641 |
113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42611497 |
114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42225146 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41553217 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41526676 |
117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40917683 |
118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40639170 |
119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40156897 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39823470 |
121 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39464637 |
122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39304426 |
123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.38890399 |
124 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38672423 |
125 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38545406 |
126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38011627 |
127 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35805815 |
128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34925906 |
129 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34124745 |
130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33808237 |
131 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33663313 |
132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.33558422 |
133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33229957 |
134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33180258 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.21609570 |
2 | MP0005360_urolithiasis | 7.50428025 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.43512322 |
4 | MP0005365_abnormal_bile_salt | 6.13348881 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06327598 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.20131965 |
7 | MP0003252_abnormal_bile_duct | 3.86338852 |
8 | MP0010329_abnormal_lipoprotein_level | 3.61361718 |
9 | MP0009840_abnormal_foam_cell | 3.31473455 |
10 | MP0005083_abnormal_biliary_tract | 3.23946079 |
11 | MP0003195_calcinosis | 2.80411357 |
12 | MP0005332_abnormal_amino_acid | 2.72739146 |
13 | MP0001666_abnormal_nutrient_absorption | 2.62323928 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.53147232 |
15 | * MP0000609_abnormal_liver_physiology | 2.14948273 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.11365829 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.09754768 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.99939838 |
19 | MP0003868_abnormal_feces_composition | 1.91494324 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81942416 |
21 | MP0001764_abnormal_homeostasis | 1.61287301 |
22 | MP0009697_abnormal_copulation | 1.56516885 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55813619 |
24 | MP0003011_delayed_dark_adaptation | 1.43019718 |
25 | MP0005451_abnormal_body_composition | 1.35862000 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.26150619 |
27 | MP0003186_abnormal_redox_activity | 1.22518225 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.21625408 |
29 | MP0009643_abnormal_urine_homeostasis | 1.21621604 |
30 | MP0000598_abnormal_liver_morphology | 1.19050764 |
31 | MP0000604_amyloidosis | 1.15660685 |
32 | MP0005647_abnormal_sex_gland | 1.14628123 |
33 | MP0002254_reproductive_system_inflammat | 1.10472971 |
34 | MP0009764_decreased_sensitivity_to | 1.08947138 |
35 | MP0010368_abnormal_lymphatic_system | 1.07577222 |
36 | MP0009763_increased_sensitivity_to | 1.05818676 |
37 | MP0005636_abnormal_mineral_homeostasis | 0.92476465 |
38 | MP0008469_abnormal_protein_level | 0.91546791 |
39 | MP0009642_abnormal_blood_homeostasis | 0.87732794 |
40 | MP0005408_hypopigmentation | 0.84786861 |
41 | MP0005670_abnormal_white_adipose | 0.83689965 |
42 | MP0003879_abnormal_hair_cell | 0.82997962 |
43 | MP0009765_abnormal_xenobiotic_induced | 0.79750719 |
44 | MP0005220_abnormal_exocrine_pancreas | 0.78424428 |
45 | MP0005376_homeostasis/metabolism_phenot | 0.78223730 |
46 | MP0005084_abnormal_gallbladder_morpholo | 0.78076990 |
47 | MP0006036_abnormal_mitochondrial_physio | 0.77892262 |
48 | MP0002078_abnormal_glucose_homeostasis | 0.77158912 |
49 | MP0002282_abnormal_trachea_morphology | 0.76898637 |
50 | MP0001915_intracranial_hemorrhage | 0.75575516 |
51 | MP0002971_abnormal_brown_adipose | 0.74214518 |
52 | MP0002876_abnormal_thyroid_physiology | 0.73212802 |
53 | MP0001661_extended_life_span | 0.72554614 |
54 | MP0009785_altered_susceptibility_to | 0.70019094 |
55 | MP0004130_abnormal_muscle_cell | 0.69971904 |
56 | MP0003690_abnormal_glial_cell | 0.69947726 |
57 | MP0005334_abnormal_fat_pad | 0.69196884 |
58 | MP0002249_abnormal_larynx_morphology | 0.67871606 |
59 | MP0009053_abnormal_anal_canal | 0.66844795 |
60 | MP0005535_abnormal_body_temperature | 0.65033107 |
61 | MP0005187_abnormal_penis_morphology | 0.64145839 |
62 | MP0003329_amyloid_beta_deposits | 0.63180586 |
63 | MP0000639_abnormal_adrenal_gland | 0.61998602 |
64 | MP0005266_abnormal_metabolism | 0.61105045 |
65 | MP0005464_abnormal_platelet_physiology | 0.61012541 |
66 | MP0005023_abnormal_wound_healing | 0.60608144 |
67 | MP0001756_abnormal_urination | 0.57312690 |
68 | MP0005448_abnormal_energy_balance | 0.56568731 |
69 | MP0006035_abnormal_mitochondrial_morpho | 0.53921767 |
70 | MP0002332_abnormal_exercise_endurance | 0.53886528 |
71 | MP0004782_abnormal_surfactant_physiolog | 0.52626223 |
72 | MP0005395_other_phenotype | 0.51823177 |
73 | MP0003724_increased_susceptibility_to | 0.51821920 |
74 | MP0003436_decreased_susceptibility_to | 0.49037716 |
75 | MP0003638_abnormal_response/metabolism_ | 0.47428327 |
76 | MP0002822_catalepsy | 0.45431905 |
77 | MP0002136_abnormal_kidney_physiology | 0.45102550 |
78 | MP0005058_abnormal_lysosome_morphology | 0.44973438 |
79 | MP0002928_abnormal_bile_duct | 0.44611512 |
80 | MP0008873_increased_physiological_sensi | 0.44466819 |
81 | MP0003718_maternal_effect | 0.44408776 |
82 | MP0008874_decreased_physiological_sensi | 0.43644641 |
83 | MP0003075_altered_response_to | 0.42202048 |
84 | MP0005248_abnormal_Harderian_gland | 0.40963734 |
85 | MP0005166_decreased_susceptibility_to | 0.40669860 |
86 | MP0003953_abnormal_hormone_level | 0.39880516 |
87 | MP0000579_abnormal_nail_morphology | 0.39870992 |
88 | MP0005666_abnormal_adipose_tissue | 0.38687914 |
89 | MP0002837_dystrophic_cardiac_calcinosis | 0.38196100 |
90 | MP0009384_cardiac_valve_regurgitation | 0.38101679 |
91 | MP0000467_abnormal_esophagus_morphology | 0.35353250 |
92 | MP0000249_abnormal_blood_vessel | 0.35004000 |
93 | MP0004883_abnormal_blood_vessel | 0.34140555 |
94 | MP0009672_abnormal_birth_weight | 0.33966453 |
95 | MP0002168_other_aberrant_phenotype | 0.33447505 |
96 | MP0008872_abnormal_physiological_respon | 0.33402819 |
97 | MP0004381_abnormal_hair_follicle | 0.33223593 |
98 | MP0009115_abnormal_fat_cell | 0.32901959 |
99 | MP0001851_eye_inflammation | 0.32824855 |
100 | MP0002796_impaired_skin_barrier | 0.32455613 |
101 | MP0001243_abnormal_dermal_layer | 0.31885867 |
102 | MP0003646_muscle_fatigue | 0.31672099 |
103 | MP0006082_CNS_inflammation | 0.30744026 |
104 | MP0002970_abnormal_white_adipose | 0.30559435 |
105 | MP0001853_heart_inflammation | 0.30415300 |
106 | MP0001545_abnormal_hematopoietic_system | 0.29643939 |
107 | MP0005397_hematopoietic_system_phenotyp | 0.29643939 |
108 | MP0001881_abnormal_mammary_gland | 0.29616458 |
109 | MP0001845_abnormal_inflammatory_respons | 0.29572739 |
110 | MP0000230_abnormal_systemic_arterial | 0.29408232 |
111 | MP0005164_abnormal_response_to | 0.28635893 |
112 | MP0002132_abnormal_respiratory_system | 0.27050085 |
113 | MP0002060_abnormal_skin_morphology | 0.25274597 |
114 | MP0000427_abnormal_hair_cycle | 0.25106651 |
115 | MP0002419_abnormal_innate_immunity | 0.24831723 |
116 | MP0003959_abnormal_lean_body | 0.22644200 |
117 | MP0002128_abnormal_blood_circulation | 0.22363698 |
118 | MP0000920_abnormal_myelination | 0.21900097 |
119 | MP0005025_abnormal_response_to | 0.20901036 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.55993213 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.30883719 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.25120451 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.72777367 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63889308 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.41764777 |
7 | Xanthomatosis (HP:0000991) | 6.26259970 |
8 | Complement deficiency (HP:0004431) | 5.65271637 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.61413150 |
10 | Joint hemorrhage (HP:0005261) | 4.94665817 |
11 | Hypolipoproteinemia (HP:0010981) | 4.84608983 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.84107345 |
13 | Hyperammonemia (HP:0001987) | 4.55006349 |
14 | Epidermoid cyst (HP:0200040) | 4.53347030 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43839479 |
16 | Hyperglycinemia (HP:0002154) | 4.35167955 |
17 | Hypoalphalipoproteinemia (HP:0003233) | 4.26815592 |
18 | Abnormality of methionine metabolism (HP:0010901) | 4.24266501 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20715300 |
20 | Ketosis (HP:0001946) | 4.17459823 |
21 | Fat malabsorption (HP:0002630) | 4.14212505 |
22 | Abnormality of complement system (HP:0005339) | 4.12824976 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09149711 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08454748 |
25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88617185 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81420793 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.81420793 |
28 | Hypoglycemic coma (HP:0001325) | 3.80461781 |
29 | Hyperglycinuria (HP:0003108) | 3.78889600 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77298100 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74304257 |
32 | Hypercholesterolemia (HP:0003124) | 3.62899383 |
33 | Spontaneous abortion (HP:0005268) | 3.57816242 |
34 | Hyperbilirubinemia (HP:0002904) | 3.29007817 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25479097 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22018627 |
37 | Steatorrhea (HP:0002570) | 3.09872951 |
38 | Myocardial infarction (HP:0001658) | 3.02969209 |
39 | Delayed CNS myelination (HP:0002188) | 3.01436126 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00727719 |
41 | Abnormality of serum amino acid levels (HP:0003112) | 2.99773286 |
42 | Hypochromic microcytic anemia (HP:0004840) | 2.98043118 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.97777609 |
44 | Ketoacidosis (HP:0001993) | 2.93652337 |
45 | Systemic lupus erythematosus (HP:0002725) | 2.84817907 |
46 | Skin nodule (HP:0200036) | 2.81600755 |
47 | Metabolic acidosis (HP:0001942) | 2.68737868 |
48 | Purpura (HP:0000979) | 2.65609084 |
49 | Glomerulonephritis (HP:0000099) | 2.65381010 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.62442528 |
51 | Acanthocytosis (HP:0001927) | 2.62186404 |
52 | Vascular calcification (HP:0004934) | 2.58747574 |
53 | Amyloidosis (HP:0011034) | 2.54082775 |
54 | Lethargy (HP:0001254) | 2.53458177 |
55 | Gingival bleeding (HP:0000225) | 2.50946951 |
56 | Osteomalacia (HP:0002749) | 2.48923505 |
57 | Hypoglycemic seizures (HP:0002173) | 2.47383080 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46446695 |
59 | Dicarboxylic aciduria (HP:0003215) | 2.46446695 |
60 | Abnormal gallbladder morphology (HP:0012437) | 2.46000551 |
61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45151469 |
62 | Spastic diplegia (HP:0001264) | 2.44937192 |
63 | Mitral stenosis (HP:0001718) | 2.43839972 |
64 | Gout (HP:0001997) | 2.42265489 |
65 | Cholelithiasis (HP:0001081) | 2.40620530 |
66 | Cholecystitis (HP:0001082) | 2.38426516 |
67 | Abnormal gallbladder physiology (HP:0012438) | 2.38426516 |
68 | Cerebral edema (HP:0002181) | 2.34560475 |
69 | Neonatal hypoglycemia (HP:0001998) | 2.33889203 |
70 | Fair hair (HP:0002286) | 2.32903253 |
71 | Irritability (HP:0000737) | 2.30936318 |
72 | Esophageal varix (HP:0002040) | 2.30372347 |
73 | Cardiovascular calcification (HP:0011915) | 2.29767991 |
74 | Neonatal onset (HP:0003623) | 2.28837570 |
75 | Thrombophlebitis (HP:0004418) | 2.27299672 |
76 | Joint swelling (HP:0001386) | 2.23540329 |
77 | Menorrhagia (HP:0000132) | 2.23080916 |
78 | Malnutrition (HP:0004395) | 2.22888768 |
79 | Pancreatitis (HP:0001733) | 2.11491136 |
80 | Late onset (HP:0003584) | 2.10987835 |
81 | Sensorimotor neuropathy (HP:0007141) | 2.10223175 |
82 | Brushfield spots (HP:0001088) | 2.06451306 |
83 | Enlarged kidneys (HP:0000105) | 2.05914070 |
84 | Increased serum ferritin (HP:0003281) | 2.03714430 |
85 | Poikilocytosis (HP:0004447) | 2.03612468 |
86 | Hemorrhage of the eye (HP:0011885) | 2.03168504 |
87 | Vomiting (HP:0002013) | 2.01755943 |
88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00088960 |
89 | Abnormality of the gallbladder (HP:0005264) | 1.99445305 |
90 | Opisthotonus (HP:0002179) | 1.98984638 |
91 | Abnormality of the Achilles tendon (HP:0005109) | 1.98365384 |
92 | Elevated alkaline phosphatase (HP:0003155) | 1.95647299 |
93 | Abnormality of iron homeostasis (HP:0011031) | 1.94529916 |
94 | Epistaxis (HP:0000421) | 1.93338225 |
95 | Generalized aminoaciduria (HP:0002909) | 1.92475435 |
96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91631229 |
97 | Reduced antithrombin III activity (HP:0001976) | 1.90900029 |
98 | Gangrene (HP:0100758) | 1.89489888 |
99 | Hyperphosphaturia (HP:0003109) | 1.89026531 |
100 | Nephritis (HP:0000123) | 1.87953299 |
101 | Rickets (HP:0002748) | 1.87761077 |
102 | Hypophosphatemic rickets (HP:0004912) | 1.84338940 |
103 | Abnormal cartilage morphology (HP:0002763) | 1.83688157 |
104 | Abnormality of vitamin metabolism (HP:0100508) | 1.80587889 |
105 | Elevated hepatic transaminases (HP:0002910) | 1.78986034 |
106 | Hydroxyprolinuria (HP:0003080) | 1.78465311 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.78465311 |
108 | Alkalosis (HP:0001948) | 1.77924726 |
109 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77746621 |
110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77599950 |
111 | Renal cortical cysts (HP:0000803) | 1.77149572 |
112 | Status epilepticus (HP:0002133) | 1.76962501 |
113 | Cerebral palsy (HP:0100021) | 1.76663485 |
114 | Arthropathy (HP:0003040) | 1.75161917 |
115 | Pulmonary embolism (HP:0002204) | 1.72640365 |
116 | Hyperglycemia (HP:0003074) | 1.72513228 |
117 | Glycosuria (HP:0003076) | 1.71397945 |
118 | Abnormality of urine glucose concentration (HP:0011016) | 1.71397945 |
119 | Abnormal delivery (HP:0001787) | 1.69190243 |
120 | Increased mean platelet volume (HP:0011877) | 1.67555859 |
121 | Bifid scrotum (HP:0000048) | 1.66773148 |
122 | Atrioventricular block (HP:0001678) | 1.65173632 |
123 | Generalized hypopigmentation of hair (HP:0011358) | 1.61511643 |
124 | Abnormal platelet volume (HP:0011876) | 1.54333054 |
125 | Abnormal urine phosphate concentration (HP:0012599) | 1.51639428 |
126 | Impaired platelet aggregation (HP:0003540) | 1.50272635 |
127 | Abnormal platelet function (HP:0011869) | 1.50272635 |
128 | Abnormal biliary tract physiology (HP:0012439) | 1.49707839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.89650830 |
2 | ERN1 | 4.81845482 |
3 | FGFR4 | 4.73564586 |
4 | SIK1 | 4.39153417 |
5 | TAOK3 | 3.15071357 |
6 | ERBB4 | 3.01613177 |
7 | INSRR | 2.99169195 |
8 | MAP2K4 | 2.29691042 |
9 | PRPF4B | 2.26572884 |
10 | OBSCN | 2.24746079 |
11 | NTRK3 | 2.21146667 |
12 | MST1R | 2.13624703 |
13 | PKN2 | 2.11471201 |
14 | TRIB3 | 1.92693800 |
15 | MAPK11 | 1.91249360 |
16 | FLT3 | 1.78687819 |
17 | PIK3CG | 1.76878056 |
18 | TYK2 | 1.76486405 |
19 | LATS1 | 1.73901998 |
20 | DAPK2 | 1.58215624 |
21 | PTK6 | 1.55899442 |
22 | NEK9 | 1.44937951 |
23 | TNK2 | 1.44002682 |
24 | FGFR2 | 1.43743270 |
25 | ABL2 | 1.41191263 |
26 | FRK | 1.36216287 |
27 | KDR | 1.31156880 |
28 | NLK | 1.30406268 |
29 | JAK2 | 1.26991718 |
30 | ZAP70 | 1.21954685 |
31 | MAP3K7 | 1.18933082 |
32 | JAK1 | 1.11085199 |
33 | ERBB2 | 1.10726619 |
34 | PRKAA2 | 1.09765852 |
35 | EPHB1 | 1.07671988 |
36 | EPHA3 | 1.05471591 |
37 | TBK1 | 1.05166520 |
38 | MAP2K3 | 1.05094656 |
39 | GRK6 | 1.02154795 |
40 | PINK1 | 1.02146017 |
41 | BLK | 0.99842087 |
42 | MAPK4 | 0.96512867 |
43 | MAP3K14 | 0.93151764 |
44 | PDK2 | 0.91807264 |
45 | MAP3K10 | 0.90998165 |
46 | MET | 0.88859426 |
47 | PRKCZ | 0.88785363 |
48 | PRKG1 | 0.88106634 |
49 | TIE1 | 0.87785915 |
50 | MAP3K2 | 0.85937556 |
51 | MAP3K3 | 0.85210044 |
52 | STK38L | 0.80655973 |
53 | CDK6 | 0.79632623 |
54 | MAPK15 | 0.78727409 |
55 | CAMK1D | 0.78055008 |
56 | MAPK12 | 0.77441956 |
57 | FER | 0.76753389 |
58 | MAP3K11 | 0.75219683 |
59 | PRKACG | 0.75087732 |
60 | RIPK1 | 0.74104866 |
61 | PRKACA | 0.73622525 |
62 | CAMK2G | 0.70740775 |
63 | CSK | 0.70198791 |
64 | GSK3A | 0.69168661 |
65 | FGFR3 | 0.68944559 |
66 | DYRK1B | 0.67842129 |
67 | MAP4K1 | 0.67839070 |
68 | TGFBR2 | 0.66531696 |
69 | CAMKK2 | 0.64184300 |
70 | PHKG2 | 0.63870800 |
71 | PHKG1 | 0.63870800 |
72 | PRKAA1 | 0.63167829 |
73 | SGK3 | 0.62083861 |
74 | MAP2K6 | 0.60556740 |
75 | KSR2 | 0.60284621 |
76 | MAPKAPK3 | 0.58913242 |
77 | IRAK3 | 0.57036544 |
78 | MAPK7 | 0.56171392 |
79 | IKBKE | 0.56048551 |
80 | PTK2 | 0.55380697 |
81 | CSF1R | 0.54731952 |
82 | STK38 | 0.52845265 |
83 | PDPK1 | 0.50181375 |
84 | PRKCQ | 0.47770441 |
85 | RPS6KA3 | 0.47622477 |
86 | PRKACB | 0.47258414 |
87 | CSNK1D | 0.47252057 |
88 | PKN1 | 0.45330926 |
89 | MAP2K1 | 0.45188228 |
90 | SGK2 | 0.44991714 |
91 | PRKCB | 0.44690970 |
92 | CSNK1G1 | 0.44425958 |
93 | RET | 0.44256074 |
94 | MAP3K5 | 0.43985328 |
95 | GRK1 | 0.43861080 |
96 | IGF1R | 0.42616131 |
97 | MYLK | 0.42338572 |
98 | EPHA4 | 0.39778794 |
99 | TTN | 0.39354254 |
100 | MAP3K13 | 0.39231742 |
101 | ICK | 0.38522733 |
102 | MTOR | 0.38088008 |
103 | TAOK2 | 0.37862335 |
104 | CDK4 | 0.37750585 |
105 | SGK1 | 0.37408708 |
106 | MUSK | 0.37312212 |
107 | EGFR | 0.37049715 |
108 | CAMKK1 | 0.35984392 |
109 | PRKCG | 0.35702566 |
110 | MAP3K6 | 0.35508880 |
111 | CSNK1E | 0.34028221 |
112 | IRAK1 | 0.33605666 |
113 | MAP3K1 | 0.32345620 |
114 | JAK3 | 0.32251486 |
115 | CAMK4 | 0.31736236 |
116 | SGK494 | 0.30876011 |
117 | SGK223 | 0.30876011 |
118 | CAMK1G | 0.30111628 |
119 | PDK1 | 0.28849773 |
120 | LATS2 | 0.26934836 |
121 | MAP2K2 | 0.23649521 |
122 | PRKCA | 0.23362915 |
123 | ABL1 | 0.23161598 |
124 | BMX | 0.22692272 |
125 | CSNK1G2 | 0.22445247 |
126 | PBK | 0.21747372 |
127 | PIK3CA | 0.21347179 |
128 | PAK3 | 0.20118953 |
129 | IRAK2 | 0.19016664 |
130 | CSNK1G3 | 0.18860989 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.51703150 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74875092 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44197812 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31371323 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11250095 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.94896848 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68621746 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65339665 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61120510 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54892867 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46638257 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34807306 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20879238 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10858073 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09540987 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.04698723 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91381433 |
18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90732718 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90009659 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89425890 |
21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88355057 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87622913 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86873769 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80012880 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75599534 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74656487 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69595140 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68573551 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65722392 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63845773 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58800285 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57109820 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56251080 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51313405 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50410157 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.49656991 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43164089 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33609301 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32255070 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30562356 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29095583 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26335043 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.22624657 |
44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21507548 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20876288 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20664512 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19299578 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11467945 |
49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03217189 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01025173 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98551312 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96755889 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94467304 |
54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93009524 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92041702 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88554983 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87628213 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85215779 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79879191 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75739119 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68568296 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67933237 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62465413 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58186689 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54867324 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45118795 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44634294 |
68 | Prion diseases_Homo sapiens_hsa05020 | 0.39416781 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39318521 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25735223 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.24930674 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24318459 |
73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23700127 |
74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23405552 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19979350 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18075747 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16477963 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10528711 |
79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08050947 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02892186 |
81 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2603721 |
82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2590488 |
83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2299262 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2254745 |
85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2250102 |
86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2221016 |
87 | Pertussis_Homo sapiens_hsa05133 | -0.2209759 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2171816 |
89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1897259 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1834387 |
91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1802881 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1695892 |
93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1663140 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1634839 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1529804 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1519506 |
97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1495215 |
98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1493324 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1470452 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1324526 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1136212 |
102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0946206 |
103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0864551 |
104 | Mineral absorption_Homo sapiens_hsa04978 | -0.0733111 |
105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0720561 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0586467 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0579876 |
108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0268964 |